International Pharmaceutical Transparency Act of 2019
This bill prohibits the sale of a drug if its label fails to list the country of origin of each of the drug's active ingredients.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.